title: Role of medications in symptomatic hyperkalemia.
authors: S
authors: S
authors: Kurisu
authors: I
authors: I
authors: Inoue
authors: T
authors: T
authors: Kawagoe
authors: M
authors: M
authors: Ishihara
authors: Y
authors: Y
authors: Shimatani
authors: Y
authors: Y
authors: Nakama
authors: T
authors: T
authors: Maruhashi
authors: E
authors: E
authors: Kagawa
authors: K
authors: K
authors: Dai
authors: T
authors: T
authors: Aokage
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects; D000368:Aged; D000369:Aged, 80 and over; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects; D005260:Female; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists / Q000009:adverse effects
chemical_list: D000317:Adrenergic alpha-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000451:Mineralocorticoid Receptor Antagonists